Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global cystatin C assay market 3600 synopsis, 2018 – 2032
2.1.1 Regional trends
2.1.2 Product trends
2.1.3 Sample type trends
2.1.4 Method trends
2.1.5 Application trends
2.1.6 End-use trends
Chapter 3 Cystatin C Assay Industry Insights
3.1 Industry ecosystem analysis
3.2 Technology landscape
3.3 Regulatory landscape
3.4 Industry impact forces
3.4.1 Growth drivers
3.4.1.1 Increasing adoption of point of care testing
3.4.1.2 Rising prevalence of chronic kidney diseases
3.4.1.3 Technological advancements in assay methodologies
3.4.1.4 Growing geriatric population base
3.4.2 Industry pitfalls & challenges
3.4.2.1 Stringent regulatory framework
3.4.2.2 Dearth of skilled professionals
3.5 Growth potential analysis
3.5.1 By product
3.5.2 By sample type
3.5.3 By method
3.5.4 By application
3.5.5 By end-use
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Competitive analysis of major market players, 2023
4.3 Company market share analysis, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic outlook matrix, 2023
Chapter 5 Cystatin C Assay Market Size and Forecast, By Product, 2018-2032 (USD Million)
5.1 Key trends, by product
5.2 Kits
5.3 Reagents
5.4 Analyzers
Chapter 6 Cystatin C Assay Market Size and Forecast, By Sample Type, 2018-2032 (USD Million)
6.1 Key trends, by sample type
6.2 Blood
6.3 Urine
Chapter 7 Cystatin C Assay Market Size and Forecast, By Method, 2018-2032 (USD Million)
7.1 Key trends, by method
7.2 Enzyme-linked immunosorbent assay (ELISA)
7.3 Particle-enhanced turbidimetric immunoassay (PETIA)
7.4 Particle-enhanced nephelometric immunoassay (PENIA)
7.5 Chemiluminescent immunoassay (CLIA)
7.6 Immunofluorescence assay
7.7 Other methods
Chapter 8 Cystatin C Assay Market Size and Forecast, By Application, 2018-2032 (USD Million)
8.1 Key trends, by application
8.2 Diagnostics
8.3 Research
Chapter 9 Cystatin C Assay Market Size and Forecast, By End-use, 2018-2032 (USD Million)
9.1 Key trends, by end-use
9.2 Hospitals
9.3 Clinical laboratories
9.4 Pharmaceutical and biotechnology companies
9.5 Other end-users
Chapter 10 Cystatin C Assay Market Size and Forecast, By Region, 2018-2032 (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 South Africa
10.6.3 UAE
10.6.4 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 Roche Diagnostics Limited
11.2 Siemens Healthineers AG
11.3 Abbott Laboratories
11.4 Beckman Coulter (Danaher Corporation)
11.5 Thermo Fisher Scientific Inc.
11.6 bioMérieux SA
11.7 Sysmex Corporation
11.8 Randox Laboratories
11.9 DiaSorin
11.10 Agilent Technologies Inc.
11.11 Bio-Rad Laboratories Inc
11.12 Abcam Plc
11.13 DiaSys Diagnostic Systems GmbH
11.14 Sino Biological, Inc.
11.15 Bio-Techne Corporation
